Y-Intercept (HK)’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-26,333
| Closed | -$934K | – | 1612 |
|
|
2024
Q1 | $934K | Buy |
26,333
+6,761
| +35% | +$240K | 0.07% | 416 |
|
|
2023
Q4 | $852K | Buy |
+19,572
| New | +$852K | 0.08% | 375 |
|
|
2023
Q3 | – | Sell |
-10,846
| Closed | -$446K | – | 1288 |
|
|
2023
Q2 | $446K | Buy |
10,846
+1,797
| +20% | +$73.9K | 0.05% | 599 |
|
|
2023
Q1 | $520K | Buy |
9,049
+3,750
| +71% | +$215K | 0.06% | 511 |
|
|
2022
Q4 | $297K | Sell |
5,299
-18,867
| -78% | -$1.06M | 0.04% | 659 |
|
|
2022
Q3 | $1.02M | Buy |
24,166
+6,976
| +41% | +$296K | 0.1% | 296 |
|
|
2022
Q2 | $929K | Buy |
17,190
+3,988
| +30% | +$216K | 0.12% | 252 |
|
|
2022
Q1 | $848K | Buy |
13,202
+7,517
| +132% | +$483K | 0.19% | 148 |
|
|
2021
Q4 | $381K | Buy |
+5,685
| New | +$381K | 0.09% | 323 |
|